Home >> Entrepreneurs >> Impact Centre Companies >> Oxalys Pharmaceuticals

 

Oxalys Pharmaceuticals

Oxalys Pharmaceuticals

Oxalys Pharmaceuticals is developing innovative new drugs to halt, slow, or reverse the course of neurodegenerative diseases. The Oxalys lead therapeutic is on track for a Phase I/II clinical trial and was granted orphan drug status by the FDA. It is positioned to become the first disease-modifying therapeutic for Huntington’s disease. The company also has a Parkinson’s disease preclinical program that has been co-funded by the Michael J Fox Foundation and NRC IRAP.

 https://www.oxalys.ca

Share This